down arrow

Qingdao Haier Biomedical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Industrial Manufacturing
  • ISIN: CNE100003P25
CNY
32.05
-0.1 (-0.31%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Qingdao Haier Biomedical Co., Ltd.
Why is Qingdao Haier Biomedical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.06% and Operating profit at -5.01% over the last 5 years
2
With a fall in Net Sales of -26.35%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 8 consecutive quarters
  • INTEREST(HY) At CNY 1.92 MM has Grown at 27.06%
  • ROCE(HY) Lowest at 7.71%
  • DEBT-EQUITY RATIO (HY) Highest at -35.45 %
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -4.84% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Qingdao Haier Biomedical Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Qingdao Haier Biomedical Co., Ltd.
-4.84%
-0.58
28.15%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.06%
EBIT Growth (5y)
-5.01%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
0.55
Tax Ratio
4.76%
Dividend Payout Ratio
40.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
35.57%
ROE (avg)
14.04%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
2.36
EV to EBIT
48.57
EV to EBITDA
28.30
EV to Capital Employed
3.21
EV to Sales
3.82
PEG Ratio
NA
Dividend Yield
1.47%
ROCE (Latest)
6.61%
ROE (Latest)
6.51%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -3.08% (YoY

NET SALES(Q)

Highest at CNY 681.96 MM

-14What is not working for the Company
INTEREST(HY)

At CNY 1.92 MM has Grown at 27.06%

ROCE(HY)

Lowest at 7.71%

DEBT-EQUITY RATIO (HY)

Highest at -35.45 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.43%

CASH AND EQV(HY)

Lowest at CNY 3,630.99 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.52%

Here's what is working for Qingdao Haier Biomedical Co., Ltd.
Net Sales
Highest at CNY 681.96 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Sales
At CNY 681.96 MM has Grown at 20.67%
over average net sales of the previous four periods of CNY 565.13 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost
Fallen by -3.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Qingdao Haier Biomedical Co., Ltd.
Interest
At CNY 1.92 MM has Grown at 27.06%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio
Highest at -35.45 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 5.43% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Cash and Eqv
Lowest at CNY 3,630.99 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 4.52%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."